Drugmaker MannKind Beats Shareholder Securities Suit
A California federal judge on Tuesday tossed a shareholder suit accusing specialty pharmaceutical company MannKind Corp. of issuing false or misleading statements in connection with poor sales of its lone product,...To view the full article, register now.
Already a subscriber? Click here to view full article